Healthcare
Live Price
Offline$159.54
-1.24% today
1Y Change
-42.14%
Window
Jun 23, 2025 โ Jun 15, 2026
Coverage: 246 bars ยท Jun 23, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Veeva Systems Inc. (VEEV) is a Healthcare stock with a market cap of $28.21B and listed on NYSE. The stock last traded around $159.54 and down 42.1% across the available one-year price window (Jun 23, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +16.3%, EPS growth of +25.9%, a dividend yield of 0.0%. What stands out right now is revenue +16.3%, EPS +25.9%, free cash flow +29.6% with operating margin 28.7% and ROIC 9.5%. Valuation already assumes a fairly strong business story at P/E 31.0 and price/sales 8.8. Stock Foundry combines VEEV price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+16.3% vs +7.6% peer median
Operating Margin
Above sector median
+28.7% vs +19.4% peer median
P/E
Below sector median
31.0 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Jun 3, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +16.3% and EPS at +25.9%, with operating margin around 28.7%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -6.8% over the next 5 trading days and finished higher after 0 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Jun 3, 2026 | โ | -0.1% | -8.4% | โ |
2026 Mar 4, 2026 | +6.2% | +4.0% | -0.7% | -8.4% |
2025 Nov 20, 2025 | +4.6% | -9.8% | -11.2% | -18.0% |
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VEEV
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
VEEV Max Drawdown
-50.55%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for VEEV and SPY.

Company Overview
Veeva Systems Inc.
New York Stock Exchange
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.